AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation. Learn more

Propel Research Forward.

A Pivotal Study of the NanoKnife System for Ablation of Prostate Tissue in an Intermediate-Risk Patient Population.

Discovering the efficacy of IRE treatment with those diagnosed with stage III pancreatic cancer. Learn more about participating sites.